Global Vaccines

Global Vaccines

This report forecasts for 2018 through 2024 global demand for human vaccines by pediatric and adult product groups in nominal US dollars at the manufacturer level. Global demand for pediatric vaccines is segmented in terms of: pneumococcal; combination; measles, mumps, and rubella; varicella; and other pediatric vaccines such as polio, hepatitis, and haemophilus influenzae type b. Global demand for adult vaccines is segmented in terms of: influenza; cervical cancer; hepatitis; pneumococcal; and other adult vaccines such as meningococcal, diphtheria, and shingles.

Discussion in this report focuses on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable. Discussion of emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria, is substantially excluded.

Total global demand for vaccines is also segmented in terms of major world region, including: US, European Union (EU). Japan, China, South America, India, North America/Caribbean (except US), and Rest of World.

Segmentation of country-specific demand in terms of adult and pediatric vaccines is not included.

To illustrate historical trends, world, product group (including their product segments), and regional demand are provided for 2015-2017.

All data reflects the most current available information. Because reporting agencies, such as the WHO and/or CDC, often require additional time to collect and present information, some data is not as current as might be desired. In some cases, estimates are made to give readers a better understanding of present-day situations. In others, where absolute precision is required, slightly older statistics are used. Where it is deemed important to understand current trends, historical information is provided.

Unless otherwise indicated, both historical and forecasted market values are expressed in US dollars at a fixed 2017 rate of exchange with local currencies.

Other various topics, including profiles of pertinent leading suppliers, are covered in this report. A full outline of report items by page is available in the Table of Contents.